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Abstract
Health services that aim to prevent and manage chronic kidney disease (CKD) in rural and remote Aboriginal communities 
in Australia, including the Goldfields region of Western Australia (WA), require innovative approaches. Nursing roles can 
significantly improve access to renal services in rural and remote areas as they are able to address a range of renal health 
promotion and prevention activities, and provide renal clinical education and support to Aboriginal people. The Goldfields 
Kidney Disease Nursing Management Program (GKDNMP), funded through the Council of Australian Governments (COAG) 
National Partnership Agreements, was developed to provide a comprehensive approach to primary health care that incorporates 
a range of health promotion and disease management activities. In the first year, the program increased home dialysis rates and 
decreased patient travel due to expanded access to renal care within the region. Context-specific health programs generated in 
response to local needs can be successful in addressing specific health care challenges in rural and remote health.
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Aim 
The aim of this paper is to report on a nurse-managed model 
of care to improve renal care in rural and remote Aboriginal 
communities in the Goldfields region of WA. The GKDNMP 
has been developed using key indicators identified by 
COAG who funded the three-year program. The program 
aims to improve renal health services in the region through 
improved access to local renal services to reduce relocation 
to Perth. Program staff provide screening and early detection 
of Aboriginal people at risk of, or with, CKD and provide 
appropriate management and comprehensive care across the 
disease continuum. The program operates in consultation with 
Aboriginal communities and uses and promotes culturally secure 
practices in care delivery. 
Background
Major disease-specific, health-related measures in Australia vary 
between Aboriginal and non-Aboriginal people. Chronic kidney 
disease (CKD) exemplifies this as Aboriginal Australians were 
five times more likely than non-Aboriginal people to have CKD 
recorded on their death certificate between 2003 and 2007 
(Australian Institute of Health and Welfare, 2010). CKD refers to 
all diseases of the kidney where a person has evidence of kidney 
damage and/or reduced kidney function that lasts for more than 
three months (Australian Institute of Health and Welfare, 2009). 
A person with end-stage kidney disease has over 85% loss of 
kidney function and requires renal replacement therapy, such 
as dialysis or transplantation, to continue life for an extended 
period of time (Kidney Health Australia, 2012). Supportive 
care without dialysis or transplantation is an alternative option 
that provides palliative symptom management (Davison, 2011; 
Sedgewick, Noble, Ho, Kafkia & Van Waeleghem, 2010).
Factors that increase the risk of CKD can be predetermined 
such as age, family history, ethnicity and gender. Other factors 
are behavioural (for example, tobacco smoking, nutrition and 
inactivity) or may be due to underlying health conditions 
including diabetes, hypertension, cardiovascular disease, 
obesity and systemic diseases (Australian Institute of Health 
and Welfare, 2009; Chadban et al., 2003; White et al., 2011; 
White, Polkinghorne, Atkins & Chadban, 2010). The five 
major causes of CKD death include circulatory diseases, 
diabetes, cancer, respiratory diseases, injury and poisoning, 
compounded by lifestyle and risk behaviour and limited 
access to effective services (Department of Indigenous Affairs, 
2008). The identification of early-stage CKD and early 
prevention of progression is critical to ensure people receive 
appropriate management to delay, minimise or halt disease 
progression (Kidney Health Australia, 2012). This may include 
fluid management, cessation of nephrotoxic medication and 
commencement of angiotensin converting enzyme inhibitors 
(Sinclair & Bennett, 2011).
Nursing has a significant role in facilitating equity in health care 
and improved access to services and health care outcomes. The 
broad scope of the role and its application in rural and remote 
communities beyond the acute setting has been previously 
noted and requires full use of the role of nurses (Cerasa, 2011; 
Van Camp, Huybrechts, Van Rompaey & Elseviers, 2011). 
While nursing roles in rural areas tend to be generalist (Francis 
& Mills, 2011), an increased number of nurse practitioners 
(NPs) working in remote areas is required (Wakerman, Curry 
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& McEldowney, 2012), and could further support nurse-led 
management of Aboriginal patients with renal disease.
CKD in the Goldfields region of Western Australia
The prevalence of stage 3 and 4 CKD has been estimated to 
be 83,000 and 2,265 with stage 4 and 5 CKD, based on a state 
population of approximately 755,000 people aged 45 years or 
older (Western Australia Department of Health, 2008). In 2009 
the incidence of patients undergoing dialysis in WA reflected a 
nationwide stabilising trend (Grace, Excell, Dent & McDonald, 
2008); however, previously reported linear projections predict 
an annual increase of 6.3% (Western Australia Department of 
Health, 2008). This is a predicted increase from 330 people in 
2010 to 670 in 2021 (WACHS, 2010).
The Goldfields region is the largest of nine government regions 
in WA, with approximately 58,727 residents living in 10 major 
regional towns and 17 remote Aboriginal communities (Figure 
1). Kalgoorlie is the largest town in the region, with remote 
communities loosely clustered around Kalgoorlie, and the 
towns of Leonora, Laverton, Warburton and Tjuntjuntjara. An 
estimated 8% of the regional population is of Aboriginal descent 
with a wide variance in the percentage of Aboriginal people 
in these towns, including 9% in Kalgoorlie, 42% in Laverton, 
and 89% in Ngaanyatjarraku Shire. This is compared to three 
per cent population of Aboriginal descent for WA as a whole 
(Government of Western Australia, 2011).
The incidence and prevalence of CKD in the Goldfields 
region mirrors increases in the WA population. Projected 
increases in the prevalence of kidney disease in WA justifies 
the need to provide well-resourced programs to improve 
renal health outcomes, renal services, and access to services for 
Aboriginal people to meet increasing demands and reduce the 
gap in renal health outcomes between Aboriginal and non-
Aboriginal Australians. This paper presents the development 
and implementation of the Goldfields Kidney Disease Nursing 
Management Program (GKDNMP.)
Service availability and acceptability
Past health care services for people with CKD in the Goldfields 
region of WA were limited. People who required access to 
specialised nephrology services, CKD stage 3 and 4 education, 
and preparation for dialysis access or transplantation 
were often required to attend services in Perth. 
This involved frequent, long-distance travel as far 
as 600 km from Kalgoorlie to Perth and 1500 km 
from Warburton to Perth. Aboriginal people who 
undertook, and continue to undertake this travel, can 
suffer distress, isolation and dislocation from their 
usual social supports and environment, and encounter 
services that may not be sensitive to cultural concerns 
(Jeffries-Stokes, Stokes, McDonald, Stokes & Daly, 
2011).
Historically, specialty nephrology workforce deficits 
have impaired the successful resourcing of CKD 
services or long-term nursing programs to support 
tertiary dialysis services and the dialysis centre at 
Kalgoorlie Hospital (KH). This is despite past efforts 
of nephrologists, surgeons, vascular access nurses and 
CKD specialist nurses who conducted clinics in the Goldfields 
region. The lack of a coordinated, Kalgoorlie-based service 
was identified as a gap that needed to be addressed to provide 
specialised kidney disease management while still embracing the 
Aboriginal Health Service and local general medical practices.
Prior to program implementation, a Perth-based nephrologist 
flew into KH to attend clinics on a weekly basis. Outside 
these times, patients were managed at KH by medical staff in 
consultation with Perth-based services. The use of KH as the 
base for the GKDNMP has enabled specialised renal nurses to 
manage the program and work more closely with regional and 
remote Aboriginal communities. The nephrologist continues 
to attend clinics at KH and remote areas, supported by 
videoconferencing facilities as needed.
Program development and implementation
The GKDNMP was designed to improve the care processes 
and service delivery for people with, or at risk of, CKD living 
in remote areas. The program used the framework developed by 
the WA Renal Disease Health Network to identify seven key 
action areas to improve renal health care services. The model 
included prevention strategies; early detection and management 
of patients with CKD; preparation and care of patients suitable 
for kidney transplantation; end-of-life palliative care; appropriate 
and timely nephrologist referrals and dialysis; establishment 
of multidisciplinary clinics; and renal workforce development 
(Western Australia Department of Health, 2008).
The Western Australian Country Health Services (WACHS) 
Renal Dialysis Plan Working Party refined the model in 2010 
which informed the WACHS Renal Dialysis Plan 2010–2021 
(WACHS, 2010). Recommendations to monitor the growth 
of the regional dialysis population, review and expand existing 
satellite services, establish satellite outreach services, expand 
home dialysis services, develop services in new regional 
locations, build workforce capacity, improve transport and 
accommodation, and information systems, formed the basis of 
the federal government decision to increase funding for renal 
dialysis services in country WA (Swan, Roxon & Snowdon, 
2011).
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Figure 1. Map of Goldfields region, Western Australia and major centres, population and distances from Perth (Government of Western Australia, 2011)
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Ravensthorpe  348  540km   
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The COAG funding provided an opportunity to develop and 
implement the three-year GKDNMP with sensitivity to the 
needs of Aboriginal people and communities. The rationale for 
the development of the GKDNMP was the identification of 
a largely under-resourced CKD program, with limited staffing 
and service delivery resources for Aboriginal people in the 
Goldfields region (Western Australia Department of Health, 
2008). The aim of the GKDNMP was to enhance existing 
renal services within the Goldfields region by providing 
comprehensive prevention, health promotion, screening and 
early identification, education, case management and tertiary 
care for Aboriginal people within the region. A particular focus 
was given to improved access to renal services predominantly 
provided by nurses in metropolitan CKD programs, through 
delivery of culturally secure services developed in consultation 
with Aboriginal communities and Aboriginal-controlled health 
services in the Goldfields region (Government of Western 
Australia, 2010).
Designed to be managed by nurses, the program employed a 
clinical nurse manager, renal nurse educator, community renal 
nurse, Aboriginal health workers (AHWs) and administrative 
officer. The program structure outlined in Figure 2 shows that 
the program team is managed by a specialist renal nurse who 
functions as the program nurse manager. The nephrologist flies 
in and out of Kalgoorlie from Royal Perth Hospital (RPH) to 
join the program team for clinics. The program provides patient 
care across a number of sites. All staff are involved in renal clinics 
at KH and the remote clinics and Aboriginal communities. If 
the nephrologist is unable to fly into KH, videoconferencing 
facilities are used to support clinics at KH. Clinics at Bega 
Garnbirringu Health Service (BGHS), the Kalgoorlie-based 
Aboriginal-controlled clinic, are attended by the nephrologist 
and community renal nurse. The local Aboriginal communities 
that are readily accessed by car from KH are seen by the 
community renal nurse and AHW.
The bulk of renal care provided by the program to Aboriginal 
people is managed by the team based at KH. Aboriginal people 
and communities are supported with medication management, 
diet, dialysis and education, and support with accommodation 
and transport needs to ensure patients attend clinics or 
treatments. Nurses have a unique skill set that enables the 
provision of a range of services to support patients across the 
care continuum. Effective management is underpinned by strong 
relationships between patients and providers, characterised by 
good communication and trust (Wakerman et al., 2012). The 
program engages a range of nursing roles to support this process 
and through strong nursing leadership, effective communication, 
team focus, and cultural sensitivity, Aboriginal communities have 
been engaged and supported the program.
The benefit of this approach rests with the range of knowledge 
and skills nurses are able to provide in working with Aboriginal 
people across the care continuum. Delays in staff recruitment 
and in the development of strategies and services, however, 
were experienced from September 2010 to May 2011, partly 
due to the availability and confirmation of funding. Despite the 
delays, the positions have been able to provide culturally secure, 
accessible renal health care services and an appropriate system to 
support patients close to their home and social supports in the 
remote Goldfields region. Moreover, the high level of skill and 
knowledge of the specialised staff enable nursing staff to backfill 
or accommodate positions for short periods of time, if required.
Staff recruitment, culturally secure service provision, community 
consultations, and the establishment and maintenance of 
effective partnerships have underpinned program development 
and facilitated appropriate and effective care pathways and 
communication protocols. These activities have been designed 
to build on primary services and improve access and delivery of 
primary, acute and subacute health care services.
Closing the Gap in Aboriginal health: GKDNMP 
development and implementation
The COAG National Partnership Agreements on Closing the 
Gap in Aboriginal health outcomes identified priority areas to 
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Figure 2. GKDNMP structure. 
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drive improvements (Australian Health Ministers’ Conference, 
2006). GKDNMP development and implementation was 
linked to outputs in Table 1 with a focus on the priority areas 
(Government of Western Australia, 2010).
Table 1: Key action areas and program outputs. (Adapted from Appendix C(2)).
Action areas Program outputs
Fixing the gaps 
and improving 
the patient 
journey
Health system Aboriginal Health Workers provided 
to coordinate and follow up care transitions.
Transport and accommodation support for rural 
and remote patients and their families.
Provision of culturally secure services and practices 
across the renal health system. 
Facilitate access to acute and sub-acute care. 
Primary health 
care services 
that can deliver
Provision of culturally secure primary health care 
service, including MBS-funded service. 
Culturally secure, multi-disciplinary chronic 
kidney disease management services to provide 
screening, education/promotion and management.
Develop communication protocols and care 
pathways to improve renal care coordination, 
referral and recall. 
Minimum service standards in place for all 
organisations providing care services for Aboriginal 
people.
Partnerships Partnerships with other renal agencies / 
stakeholders.
Community 
consultations
Appropriate renal-related community consulations.
Fixing the gaps and improving the patient journey
The AHW role was considered vital to understand different 
value systems and reduce barriers in the provision of CKD care 
with Aboriginal communities. The AHWs promote and develop 
culturally secure services and practices, coordinate follow-up 
care and transitions, arrange transport and accommodation, and 
improve access to acute and subacute care. One male AHW 
was engaged for three months. The assistance and education 
provided by the AHW contributed to a deeper understanding 
of the impact of CKD for non-Aboriginal nursing staff, and the 
development of appropriate practices and procedures.
This was achieved by the AHW through education seminars 
for health workers, contribution to the design of culturally 
appropriate educational materials, and one-on-one education 
regarding Aboriginal culture and sensitivities with KH 
haemodialysis nursing staff. Staff feedback indicated seminars 
were valuable for informing their nursing care with Aboriginal 
patients undergoing dialysis. Importantly, the AHW informally 
engaged and supported patients during each shift in the dialysis 
unit. He successfully contributed to decreased patient transfers 
from the Goldfields region to Perth, reduced patient distress, 
reduced negative impacts of relocation, increased dialysis 
attendance rates, and decreased the accommodation and travel 
costs of temporary relocation.
As a result of this program, access to subacute services has 
improved in the more remote parts of the Goldfields region. 
Renal outreach clinics are now held quarterly at Warburton and 
Laverton. The importance of a consistent renal team attending 
these clinics is vital to increase trust and confidence and improve 
attendance rates, to facilitate management of people in various 
stages of CKD in more remote areas. Monthly outpatient 
clinics at BGHS with a nephrologist and the community renal 
nurse, and weekly multidisciplinary clinics at KH, successfully 
identified greater numbers of people at stages 3 to 5 CKD. 
Due to these changes, more people access CKD stage 4 pre-
dialysis education, lifestyle education and anaemia management. 
Although the impacts of this activity cannot be measured at this 
early stage of the program, the logical impact of this activity 
will be the reduction in CKD progression to end-stage kidney 
disease requiring renal replacement therapy.
The community renal nurse role has contributed to increased 
outpatient renal clinics and consultation at KH and reduced 
transfers to RPH. This has been achieved through engagement 
with Aboriginal communities to identify Aboriginal people 
who may be unable to attend clinics without support. Transport 
and accommodation needs have been identified and these have 
then been arranged for people requiring these services. The 
respectful manner in which program staff communicate and 
work with Aboriginal people has led to strong engagement 
with Aboriginal communities and requests for additional visits 
in remote areas. The number of transfers to Perth has been 
reduced as program nurses are able to monitor people living 
in Aboriginal communities more frequently. They are able to 
undertake regular screening and assessments, improve the uptake 
of early interventions by Aboriginal people, and provide services 
at KH. In the first six months of the program, 36 patients who 
would have previously travelled to Perth for CKD management 
were able to access services at KH.
Improved attendance rates led to a 100% increase in the 
identification and management of people with CKD stage 5 
(eGFR<15 ml/min), an increase from 38 to 76 people with 
stages 4 or 5 CKD. In the initial six months of the program, 
there was a significant decrease in the number of patient 
transfers and hospital admissions to RPH. This included two 
patients who were able to receive peritoneal dialysis tube 
insertion at KH, a procedure that had previously required 
transfer to RPH and an inpatient stay of two months post-
procedure.
The GKDNMP arranged for increased support from the 
Perth-based vascular access team, who now visit KH quarterly. 
The GKDNMP assists the vascular access team by providing 
appropriate communication and education, and arranges patient 
transport to encourage attendance. Attendance rates have 
doubled in the first six months of the program. This is likely 
to improve the number of people who require dialysis with 
adequate preparation in managing their vascular access.
Access to acute services also increased in the first six months 
of the program. Dialysis patients with acute complications are 
now managed by the GKDNMP in Kalgoorlie when clinically 
appropriate. These conditions include acute fluid overload, 
peritonitis and access issues, which previously required patient 
transfers to a tertiary facility in Perth using the Royal Flying 
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Doctors Service. Again, this has contributed to decreased 
unnecessary transfers to Perth.
In the event that travel to Perth is unavoidable, established care 
plans and clinical support enable patients to remain in their local 
community until the point of transfer. For example, patients 
requiring home haemodialysis training can be supported at 
home until transfer for haemodialysis is required. This has 
reduced inpatient admissions in Perth from an average of 
three weeks to one week and lengths of stay have decreased 
through collaborative community health care, for example, 
intraperitoneal antibiotics administered remotely through 
collaboration with GKDNMP. Liaison with dialysis patients and 
families has seen attendance rates improve from 50% to 90% 
over a six-month period for dialysis patients in Kalgoorlie.
Delivering primary health care services
Primary health care has a significant role in the early detection 
and management of people with CKD. Primary health care 
responsibilities require the GKDNMP to support other services 
to improve the access to health care services for people with 
CKD. Significant progress in this area has seen a range of health 
promotion activities to raise awareness and engage communities 
in screening and education for populations at risk of CKD, and 
rural and remote health workers. Awareness-raising activities 
have included World Kidney Day, where education and 
screening was offered to the public. Over 50% of the 19 people 
screened had hypertension and were advised to see their general 
practitioner (GP) as soon as possible. Results indicate five people 
contacted the service for ongoing CKD support and education, 
an additional six agreed to a visit from the community renal 
nurse, and three attended the BGHS outpatient clinic.
CKD screening and education promotion activities in 
Kalgoorlie and more remote areas of the Goldfields region 
have been led by the community renal nurse and GKDNMP 
team in collaboration with Kidney Health Australia (KHA). 
In the six months to April 2011, five renal education sessions 
were delivered to health care providers at Laverton Hospital, 
Warburton Clinic, KH and the Edward Collick Nursing Home. 
Remote clinic nurses reported improved skills, knowledge 
and confidence regarding when to refer to other services, 
particularly for patients receiving peritoneal dialysis.
Liaison with GP network programs such as the “Heart 
Moves Program” (Heart Foundation, 2011) contributed to 
overall improvements in services aimed to decrease CKD and 
cardiovascular disease risk factors, and a structured approach 
to CKD pathology specimen collection. The GP Network 
sponsored the Kidney Check Australia Taskforce (KCAT) 
managed by KHA to provide workshops targeted for practice 
nurses and GPs. Using a series of education modules, the 
interactive learning sessions, with national accreditation and 
continuing education points, aim to improve the knowledge, 
detection and management of kidney disease in general practice 
(Kidney Health Australia, 2011). Prior to the GKDNMP, 
facilitation of these programs targeting the appropriate health 
care services had been limited.
Ongoing education has increased the capacity of GPs and 
practice nurses to provide services such as targeted screening 
and minimisation of modifiable risk factors for CKD. This 
education has improved clinicians’ confidence and knowledge, 
and strengthened relationships between GKDNMP staff, GPs 
and practices nurses. This has resulted in increased attendance 
rates at the Aboriginal Health Service rather than KH, in line 
with patient preferences.
Partnerships
The need to foster relationships and develop partnerships 
with renal-related agencies and stakeholders in order to close 
the gap has been recognised by the GKDNMP. During the 
program’s initial six months, a collaborative, problem-solving 
approach focused on patient case management was used to 
develop working relationships with local and outreach health 
facilities. The partnership and collaborative relationship, together 
with improved education, and clearer patient pathways, have 
contributed to improved patient care and reduced travel to both 
Kalgoorlie and Perth.
GKDNMP staff are actively involved in two of the four 
working groups formed to promote remote renal services, the 
Haemodialysis Model of Care, and Community Engagement 
and Health Promotion. Strong partnerships and collaboration 
with the RPH, WACHS, Fresenius Medical Care (a home 
dialysis care provider), KH, Ngaanyatjarra Health Service, 
and Western Desert Nganampa Walytja Palyantjaku Tjutaku 
(WDNWPT) have been vital to providing the best in culturally 
sensitive, coordinated renal care.
Effective collaboration with a range of staff from the above 
services has led to a number of key achievements. The most 
notable development has been a referral pathway with 
Ngaanyatjarra Lands and review form. It has led to improved 
referral and communication pathways between Kalgoorlie, 
Ngaanyatjarra Lands, Fresenius Medical Care (FMC) and 
tertiary facilities such as RPH, regarding discharge processes for 
Aboriginal patients returning to Warburton and surrounding 
areas. In addition, a home dialysis discharge and referral protocol 
and review form was developed between the Goldfields region 
and FMC.
Further collaboration has led to improved coordination 
and care delivery closer to Goldfields renal patients’ homes 
in Ngaanyatjarra Lands. The Ngaanyatjarra Health Service, 
WDNWPT, BGHS, and GKDNMP have been proactive 
in developing proposals for dialysis services at Warburton 
Hospital and BGHS health clinic to further reduce the need for 
relocation for dialysis services and address cultural sensitivities. 
Development of the BGHS dialysis service has the potential to 
provide a supported, self-care dialysis service and decrease the 
need of some patients to attend KH.
Community consultations
A feature of the GKDNMP has been an increased number and 
improved quality of community consultations. These have been 
held with a range of established Aboriginal-controlled health 
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services and council meetings with community elders. These 
groups contributed to the development and implementation 
phase of the project and continue to inform changes using a 
continuous quality improvement approach. This will include 
ongoing development of culturally relevant renal resources.
Non-Aboriginal groups have contributed to health promotion 
activities such as World Kidney Day. Public events were 
used to provide public education and screening initiatives in 
collaboration with Watercorp, Leonards Chicken Supply, and 
the Oasis Centre for Kidney Week. High attendance rates at 
education and screening days held in the community, and 
continuity of a collaborative, problem-solving approach to 
patient-centred care, have strengthened existing relationships 
with WACHS Health Services Providers, Tjuntjuntjara, 
Warburton and Laverton in outlying areas.
Discussion
Establishment of the GKDNMP has improved culturally 
secure renal health programs and access to health services for 
Aboriginal people at risk of, or with, CKD. This has been 
achieved by staff awareness and commitment to deliver the right 
care at the right place, and avoid unnecessary relocation to larger 
centres such as Kalgoorlie and Perth that results in immeasurable, 
negative personal, family and health impacts.
Program staff have improved access and culturally relevant 
services for patients and families, and improved staff confidence 
and understanding of culturally and renal-specific knowledge 
and skills. An initial challenge in recruiting AHWs provided 
opportunities to identify alternative methods to recruit to 
this role, and emphasised the need to provide support and 
clarification during the early stages of the role. Recruitment 
could be achieved through BGHS, local communities, dialysis 
patients, or transplant recipients. Mentorship programs using 
successful renal AHWs from other areas, such as Kimberly, Alice 
Springs, or Perth could be considered to provide additional 
support.
In the limited time the program has been operational, significant 
improvements in health service delivery to Aboriginal 
communities have been achieved. This has been demonstrated 
through requests from Aboriginal communities for increased 
clinics and visits, and improved clinic and dialysis attendance 
rates. A whole of health approach has been used in which the 
range of nursing skills are highlighted and the ability to work 
across the health system and beyond the acute sector. The 
approach used in this program could be applied more broadly 
to other chronic disease management programs in Aboriginal 
communities. Stronger relationships between similar programs 
and across the life continuum could improve the ability of 
programs to improve health outcomes. This could include 
diabetes, hypertension, and cardiovascular disease, for example, 
that contribute to renal disease (Australian Institute of Health 
and Welfare, 2009; Chadban et al., 2003; White et al., 2010). In 
addition to this, government policies need to address the social 
determinants of health and nursing has a significant role in 
supporting these changes (Cerasa, 2011).
Development of an NP role would further enable program 
support and can improve patient outcomes (Wakerman et al., 
2012). This role would need to be carefully scoped as it would 
require specialised renal and Aboriginal health knowledge 
and not be limited to clinical perspectives. That is, the role 
needs to be developed with the ability to influence the social 
determinants of health (Cerasa, 2011).
Limitations
The quality of the program in relation to the acceptability from 
the Aboriginal communities has not been directly addressed. 
This information has been identified anecdotally but a more 
rigorous approach undertaken with cultural sensitivity would be 
valuable.
Conclusion
The GKDNMP has achieved significant success in the majority 
of the 10 COAG outputs and improved access and delivery of 
culturally secure renal health care services. The commitment to 
improve the prevention of, and services for, people with CKD, is 
evident from the WACHS Goldfields Regional Director through 
to the renal program staff, with nursing roles central to the 
support and sustainability of these changes. This commitment 
has been demonstrated through substantial progress in only eight 
months. This early progress report has summarised many of these 
achievements and provided suggested opportunities to continue 
this program to contribute to closing the gap in renal health-
related outputs in the WACHS Goldfields region.
Nursing has a strong role in improved access and delivery of renal 
health services in remote Aboriginal communities in Australia. 
The program demonstrates the strong ability nursing has to 
improve Aboriginal health, and while improvements in renal 
health outcomes may not be noted for some time, the strong 
relationships built with Aboriginal people and communities will 
support changes in the longer term.
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